Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Ana Paula Rodrigues

Instituto Nacional de Saúde Doutor Ricardo Jorge

Portugal

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Epidemiology

100%

Virology

50%

Covid-19

70%

Sars-cov-2

60%

Pandemic Preparedness

50%

Infectious Disease

40%

Pandemic Studies

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles21

Evaluation of European severe acute respiratory infection (SARI) surveillance, 27 European countries, 2022/23

Article Link

Year:

2025

Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross‐Sectional Study From 2014 to 2019

Article Link

Year:

2024

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

Article Link

Year:

2024

Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe

Article Link

Year:

2024

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

Article Link

Year:

2024

Immune Response Against Influenza in a Cohort of Repeatedly Vaccinated Adults During the 2017/2018 and 2018/2019 Seasons

Article Link

Year:

2024

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024.

Article Link

Year:

2024

Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.

Article Link

Year:

2024

Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study

Article Link

Year:

2024

Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024

Article Link

Year:

2024

Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.

Article Link

Year:

2023

Monitoring COVID-19 and Influenza: The Added Value of a Severe Acute Respiratory Infection Surveillance System in Portugal

Article Link

Year:

2023

End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal

Article Link

Year:

2023

Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network.

Article Link

Year:

2023

COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021

Article Link

Year:

2022

Local problem solving in the Portuguese health examination survey

Article Link

Year:

2022

Temporal Variations in Respiratory Syncytial Virus Epidemics, by Virus Subtype, 4 Countries.

Article Link

Year:

2021

Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021.

Article Link

Year:

2021

Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.

Article Link

Year:

2021

mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021

Article Link

Year:

2021

Implementing an Influenza Vaccine Effectiveness Study in a Hospital Context in Portugal: The EVA Hospital Project.

Article Link

Year:

2020

Collaborators19

Heather Whitaker

Open University

UNITED KINGDOM

Irina Kislaya

Bernhard Nocht Institute for Tropical Medicine

GERMANY

Q. Sue Huang

Institute of Environmental Sciences and Research

NEW ZEALAND

Susana Silva

Instituto Nacional de Saúde Doutor Ricardo Jorge

PORTUGAL

Luise Goerlitz

Robert Koch Institute

GERMANY

Raquel Guiomar

Head of the National Influenza Reference Laboratory

Instituto Nacional de Saúde Doutor Ricardo Jorge

PORTUGAL

Ana Paula Gil

Universidade de Aveiro

PORTUGAL

Ramona Trebbien

Head of Influenza Laboratory, Senior Scientist

Statens Serum Institut

DENMARK

Marta Barreto

Invited Assistant Professor in Epidemiology

Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa

PORTUGAL

Itziar Casado

Instituto de Salud Pública de Navarra

SPAIN

Luisa Mota-Vieira

Universidade de Aveiro

PORTUGAL

Baltazar Nunes

Invited Professor

Universidade de Aveiro

PORTUGAL

Inmaculada Casas

Head of Unit

Instituto de Salud Carlos III Campus de Majadahonda

SPAIN

Amanda Bolt Botnen

Statens Serum Institut

DENMARK

André Almeida

Universidade Nova de Lisboa, NOVA Medical School | Faculdade de Ciências Médicas

PORTUGAL

Gabriel Goderski

National Institute for Public Health and the Environment

NETHERLANDS

Giedre Gefenaite

Lund University

SWEDEN

Thierry BLANCHON

FRANCE

Pedro Pechirra

Instituto Português do Mar e da Atmosfera

PORTUGAL

How do I reach out?

Meet Kite AI